Altimmune, a clinical stage biopharmaceutical company, is dedicated to developing peptide-based therapeutics in Birmingham. Their primary focus lies in creating innovative peptide treatments for obesity and liver disease.
With a commitment to advancing next generation peptide therapeutics, Altimmune aims to address critical health challenges through cutting-edge research and development efforts.
Generated from their website's infomation